Perfect J R, Lang S D, Durack D T
Antimicrob Agents Chemother. 1980 Jan;17(1):43-8. doi: 10.1128/AAC.17.1.43.
To evaluate cotrimoxazole in the treatment of bacterial meningitis, we compared its action with that of ampicillin and chloramphenicol in experimental Haemophilus influenzae type b meningitis. Both trimethoprim and sulfamethoxazole penetrated well into the cerebrospinal fluid of infected rabbits, reaching 40 and 26%, respectively, of their simultaneous serum levels. Levels measured 30 and 60 min after intravenous injection exceeded the minimum inhibitory concentration of this combination for H. influenzae by 10- to 100-fold. The mean ratio of trimethoprim to sulfamethoxazole in cerebrospinal fluid was 1:22. Cotrimoxazole was as effective as ampicillin in therapy of beta-lactamase-negative H. influenzae meningitis and as effective as chloramphenicol for a beta-lactamase positive strain. These findings corroborate favorable preliminary clinical experience reported by others and indicate that cotrimoxazole deserves further study in the therapy of bacterial meningitis.
为评估复方新诺明治疗细菌性脑膜炎的效果,我们在实验性b型流感嗜血杆菌脑膜炎中,将其作用与氨苄西林和氯霉素进行了比较。甲氧苄啶和磺胺甲恶唑均能很好地渗透到受感染兔的脑脊液中,分别达到其同期血清水平的40%和26%。静脉注射后30分钟和60分钟测得的水平比该复方制剂对流感嗜血杆菌的最低抑菌浓度高出10至100倍。脑脊液中甲氧苄啶与磺胺甲恶唑的平均比例为1:22。复方新诺明在治疗β-内酰胺酶阴性的流感嗜血杆菌脑膜炎方面与氨苄西林效果相同,在治疗β-内酰胺酶阳性菌株方面与氯霉素效果相同。这些发现证实了其他人报告的良好初步临床经验,并表明复方新诺明在细菌性脑膜炎治疗中值得进一步研究。